FLT4 and neoplasm: We therefore examined and compared the effect of combined chemotherapy with oxaliplatin/leucovorin/5-FU (FLO) versus cisplatin/leucovorin/5-FU (FLP) in patients with advanced esophagogastric cancer in relation to tumour VEGFR-3 and CXCR4 expression.